ASTS/Sanofi Fall 2022 Webinar Series
Join us on Wednesday, November 30 for an in-depth discussion of Enhancing Evaluation of Living Kidney Donors: The Road to a Paradigm Shift with speaker Richard Formica, MD, FAST, Professor of Medicine Nephrology and Surgery, Director of Transplant Medicine, Directory Outpatient Transplantation Service, and Medical Director of Adult Kidney Transplantation at Yale New Haven School of Medicine
ASTS and Sanofi are partnering together on an educational webinar series this fall!
Wednesday, December 14, 12:00 - 1:00 pm ET
Measuring Outcomes for Transplant: Using the SRTR to Improve Center Performance
Speaker: Jesse Schold, MD, PhD, M.Stat, M.Ed, Director, Center for Outcomes Research and Policy, Director, Transplant Epidemiology, and Vice Chair of Policy and Outcomes at University of Colorado
Program Objectives:
- Describe the role of government and stakeholders for the Scientific Registry of Transplant Recipients (SRTR)
- Evaluation tools that can be used to improve transplant center performance
- Review changes and models in the SRTR reports
- Examine the 5-tier rating system as an outcome assessment for transplant programs
- Evaluate and discuss the effects of measured center performance on transplant center practice
Please note that these webinars are not eligible for CME credits.
Use the link below to register for the webinar series! This will automatically register you for all 4 webinars.
Past Webinar:
Date: Wednesday, November 30
Time: 12:00 - 1:00 pm ET
Title: Enhancing Evaluation of Living Kidney Donors: The Road to a Paradigm Shift
Speaker: Richard Formica, MD, FAST, Professor of Medicine Nephrology and Surgery, Director of Transplant Medicine, Directory Outpatient Transplantation Service, and Medical Director of Adult Kidney Transplantation at Yale New Haven School of Medicine
Questions Explored:
- How do racial disparities affect the living kidney donor (LKD) evaluation process and what could contribute to this?
- What new tools are available to evaluate the risk of end-stage renal disease (ESRD) for LKDs, and how can these tools help in the donor evaluation process?
- How has HIV+ living donation helped HIV+ recipients, and how has the paradigm of living kidney donation in this population shifted over the years?
- What steps can be taken within the transplant community to better support LKDs and emphasize the need for LKD follow-up?